These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36980627)

  • 1. Role of Adjuvant Chemotherapy in Stage I Pure Ovarian Immature Teratoma: A Systematic Review and Meta-Analysis.
    Li S; Wang Y; Zhang X; Zhang T; Yin M; Yang J
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for pure ovarian immature teratoma and the role of adjuvant chemotherapy in stage I diseases.
    Li S; Zhang X; Zhang T; Yin M; Cao D; Xiang Y; Yang J
    Ann Med; 2023; 55(2):2273984. PubMed ID: 37909181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.
    Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y
    Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis.
    Bergamini A; Sarwar N; Ferrandina G; Scarfone G; Short D; Aguiar X; Camnasio C; Kaur B; Savage PM; Cormio G; Lim A; Pignata S; Mangili G; Seckl MJ
    Eur J Cancer; 2020 Sep; 137():136-143. PubMed ID: 32763784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9).
    Mangili G; Scarfone G; Gadducci A; Sigismondi C; Ferrandina G; Scibilia G; Viganò R; Tateo S; Villa A; Lorusso D
    Gynecol Oncol; 2010 Oct; 119(1):48-52. PubMed ID: 20599258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early stage ovarian immature teratoma, surveillance or chemotherapy after surgery? A propensity score matched analysis.
    Zhang X; Yang J; Wang J; Zhang Y; Yang J
    Gynecol Oncol Rep; 2022 Apr; 40():100976. PubMed ID: 35434235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study.
    Mangili G; Giorda G; Ferrandina G; Cormio G; Cassani C; Savarese A; Danese S; Carnelli M; Vasta FM; Perrone AM; Scarfone G; Pignata S; Legge F; Raspagliesi F; Taccagni G; Candiani M; Bogani G; Mascilini F; Bergamini A
    Int J Gynecol Cancer; 2021 Sep; 31(9):1242-1247. PubMed ID: 34035080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
    Mangili G; Sigismondi C; Lorusso D; Cormio G; Candiani M; Scarfone G; Mascilini F; Gadducci A; Mosconi AM; Scollo P; Cassani C; Pignata S; Ferrandina G
    Ann Oncol; 2017 Feb; 28(2):333-338. PubMed ID: 27803008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy.
    Marino G; Grassi T; De Ponti E; Negri S; Testa F; Giuliani D; Delle Marchette M; Dell'Oro C; Fumagalli D; Donatiello G; Besana G; Marchetta L; Bonazzi CM; Lissoni AA; Landoni F; Fruscio R
    Front Oncol; 2024; 14():1330481. PubMed ID: 38371620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database.
    Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb KM
    Am J Clin Oncol; 2021 May; 44(5):195-199. PubMed ID: 33710136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Adjuvant Chemotherapy on FIGO Stage I Ovarian Clear Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Yin M; Yang J; Zhou H; Liu Q; Li S; Zhang X
    Front Oncol; 2022; 12():811638. PubMed ID: 35656506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of 67 consecutive cases of pure ovarian immature teratoma.
    Li H; Hong W; Zhang R; Wu L; Liu L; Zhang W
    Chin Med J (Engl); 2002 Oct; 115(10):1496-500. PubMed ID: 12490095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative.
    Pashankar F; Hale JP; Dang H; Krailo M; Brady WE; Rodriguez-Galindo C; Nicholson JC; Murray MJ; Bilmire DF; Stoneham S; Arul GS; Olson TA; Stark D; Shaikh F; Amatruda JF; Covens A; Gershenson DM; Frazier AL
    Cancer; 2016 Jan; 122(2):230-7. PubMed ID: 26485622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance policy for stage I ovarian germ cell tumors.
    Dark GG; Bower M; Newlands ES; Paradinas F; Rustin GJ
    J Clin Oncol; 1997 Feb; 15(2):620-4. PubMed ID: 9053485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of complete surgical staging and adjuvant chemotherapy on survival in stage I, grade 1 and 2 endometrioid ovarian carcinoma.
    Swift BE; Covens A; Mintsopoulos V; Parra-Herran C; Bernardini MQ; Nofech-Mozes S; Hogen L
    Int J Gynecol Cancer; 2022 Apr; 32(4):525-531. PubMed ID: 34969829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
    Lawrie TA; Winter-Roach BA; Heus P; Kitchener HC
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD004706. PubMed ID: 26676202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy for stage i ovarian clear cell carcinoma: is it necessary for stage IA?
    Mizuno M; Kajiyama H; Shibata K; Mizuno K; Yamamuro O; Kawai M; Nakanishi T; Nagasaka T; Kikkawa F
    Int J Gynecol Cancer; 2012 Sep; 22(7):1143-9. PubMed ID: 22801028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of the Complete Surgical Staging of Stage I Malignant Ovarian Germ Cell Tumors.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Ann Surg Oncol; 2016 Sep; 23(9):2982-7. PubMed ID: 27112586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.